Want to join the conversation?
$EA said that cost of goods sold during 2Q17 is expected to be $405MM, including $13MM of amortization of intangibles. The company expects its 2Q17 GAAP OpEx to be $566MM, including about $50MM in stock-based compensation and $1MM in amortization of intangibles.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.